Cargando…

High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Maréchal, R, Demetter, P, Nagy, N, Berton, A, Decaestecker, C, Polus, M, Closset, J, Devière, J, Salmon, I, Van Laethem, J-L
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2010
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2966637/ http://dx.doi.org/10.1038/sj.bjc.6605894

Ejemplares similares

High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma
por: Maréchal, R, et al.
Publicado: (2009)

DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer
por: Drouillard, A, et al.
Publicado: (2016)

Putative contribution of CD56 positive cells in cetuximab treatment efficacy in first-line metastatic colorectal cancer patients
por: Maréchal, Raphaël, et al.
Publicado: (2010)

What Should Guide the Performance of Venous Resection During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma with Venous Contact?
por: Navez, Julie, et al.
Publicado: (2021)

Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study
por: Demols, A, et al.
Publicado: (2006)

CXCR4 Expression Predicts Early Liver Recurrence and Poor Survival After Resection of Pancreatic Adenocarcinoma
por: Liao, Wei-Chih, et al.
Publicado: (2012)

Coexpression of EGFR and CXCR4 Predicts Poor Prognosis in Resected Pancreatic Ductal Adenocarcinoma
por: Wu, Huanwen, et al.
Publicado: (2015)

SMAD4 Positive Pancreatic Ductal Adenocarcinomas Are Associated with Better Outcomes in Patients Receiving FOLFIRINOX-Based Neoadjuvant Therapy
por: Racu, Marie-Lucie, et al.
Publicado: (2023)

Preoperative treatment with mFOLFIRINOX or Gemcitabine/Nab-paclitaxel +/- isotoxic high-dose stereotactic body Radiation Therapy (iHD-SBRT) for borderline resectable pancreatic adenocarcinoma (the STEREOPAC trial): study protocol for a randomised comparative multicenter phase II trial
por: Bouchart, Christelle, et al.
Publicado: (2023)

Corrigendum to: Antemortem diagnosis of nonbacterial thrombotic endocarditis in a patient with previously resected pancreatic adenocarcinoma: a case report
Publicado: (2020)

Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma
por: Matthews, LH McCormick, et al.
Publicado: (2015)

Corrigendum to: Is Neoadjuvant Therapy Needed in Patients with Resectable Pancreatic Cancer?
por: Kim, Dong Uk
Publicado: (2023)

BMI-1 promotes invasion and metastasis in endometrial adenocarcinoma and is a poor prognostic factor
por: Yu, Jing, et al.
Publicado: (2022)

Corrigendum to “Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis”
por: Durko, L., et al.
Publicado: (2017)

Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients
por: Tonini, G, et al.
Publicado: (2005)

USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma
Publicado: (2019)

Heparanase is a prognostic indicator for postoperative survival in pancreatic carcinoma
por: Rohloff, J, et al.
Publicado: (2002)

MicroRNA-183-5p promotes the proliferation, invasion and metastasis of human pancreatic adenocarcinoma cells
por: Miao, Fei, et al.
Publicado: (2021)

Novel crosstalk between KLF4 and ZEB1 regulates gemcitabine resistance in pancreatic ductal adenocarcinoma
por: Wang, Zhiyi, et al.
Publicado: (2020)

Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”
por: Xing, Hai-Bo, et al.
Publicado: (2022)

Corrigendum: Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endoscopic Ultrasonography but Indeterminate on Computed Tomography
por: Ko, Sung Woo, et al.
Publicado: (2022)

Inhibition of Migration, Invasion and Drug Resistance of Pancreatic Adenocarcinoma Cells – Role of Snail, Slug and Twist and Small Molecule Inhibitors [Corrigendum]
Publicado: (2022)

EGFR, but not COX-2, protein in resected pancreatic ductal adenocarcinoma is associated with poor survival
por: Fagman, Johan Bourghardt, et al.
Publicado: (2019)

Overexpression of APC11 predicts worse survival in lung adenocarcinoma [Corrigendum]
Publicado: (2019)

The impact of a multidisciplinary team approach on the management of focal pancreatic lesions: a single tertiary center experience
por: Francisse, Sophie, et al.
Publicado: (2023)

Corrigendum to “In Vivo Tracking of Chemokine Receptor CXCR4-Engineered Mesenchymal Stem Cell Migration by Optical Molecular Imaging”
por: Kalimuthu, Senthilkumar, et al.
Publicado: (2020)

CXCR1 promotes malignant behavior of gastric cancer cells in vitro and in vivo in AKT and ERK1/2 phosphorylation
por: Wang, Junpu, et al.
Publicado: (2023)

CHD1L is associated with poor survival and promotes the proliferation and metastasis of intrahepatic cholangiocarcinoma
por: Li, Shimiao, et al.
Publicado: (2019)

Corrigendum to “Pain Relieving Effect of Intraoperative Chemical Splanchnicectomy of Celiac Ganglions in Patients with Resectable Pancreatic or Gastric Masses: A Randomized Clinical Trial”
por: Vahedian, Jalal, et al.
Publicado: (2021)

Undifferentiated Pancreatic Carcinoma With Osteoclast-Like Giant Cells: What Do We Know So Far?
por: Demetter, Pieter, et al.
Publicado: (2021)

Corrigendum to “CXCL12/CXCR4 signaling induced itch and pain sensation in a murine model of allergic contact dermatitis”
Publicado: (2020)

Corrigendum. Septum resection in women with a septate uterus: a cohort study
por: Rikken, J F W, et al.
Publicado: (2020)

Does type 2 diabetes influence the risk of oesophageal adenocarcinoma?
por: Neale, R E, et al.
Publicado: (2009)

Cyclam-Modified Polyethyleneimine for Simultaneous TGFβ siRNA Delivery and CXCR4 Inhibition for the Treatment of CCl4-Induced Liver Fibrosis [Corrigendum]
Publicado: (2021)

Epithelial expression of FHL2 is negatively associated with metastasis-free and overall survival in colorectal cancer
por: Verset, L, et al.
Publicado: (2013)

Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders
por: Humaidan, P., et al.
Publicado: (2017)

Corrigendum to “Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively”
por: Yu, Qi, et al.
Publicado: (2018)

GAMEC – a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours
por: Shamash, J, et al.
Publicado: (2007)

Corrigendum to “Successful Pelvic Resection for Acetabular Hydatidosis”
por: Canoville, Daniel, et al.
Publicado: (2019)

Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma
por: Yan, Ting-Ting, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nle85evvuebqd6merrrvnrkeua